The aerospace industry is undergoing a profound power architecture shift. For decades, radiation-hardened (rad-hard) silicon MOSFETs were the undisputed workhorses of spaceborne DC-DC converters.

Fifty-four people were injured and 18 are missing after an explosion at Qatar's massive Ras Laffan liquefied natural gas (LNG) complex, which occurred as workers were restarting operations halted ...

Authorities confirm deaths, say 66 injured Authorities say a 'technical accident' caused explosion Blast occurred during restart at Barzan gas supply facility DOHA, June 22 (Reuters) - Thirteen people ...

Browse projects, edit plans, run simulations, load flood results, extract flow hydrographs, and animate time steps — all inside QGIS, without opening HEC-RAS.

The missile attack that Iran launched against Qatar in mid-March sent plumes of smoke rising from the largest natural-gas production facility in the world. It destroyed sections of a plant that ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, with ...

Iranian strikes and a blockade have paralyzed Qatar’s gas engine, creating a technical bottleneck likely to stall exports for years. By River Akira Davis River Davis reported this article from Doha, ...

After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels. The Bay Area biotech has spent several ...

A Revolution Medicines drug helped pancreatic cancer patients live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in this ...